Fourth-generation safety-designed CAR T cells
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Fourth-generation safety-designed CAR T cells, covering 2014-10-20 to 2014-10-20. Get the full timeline:
Most recent: Clinical Trial Update: Evaluation of 4th Generation Safety-designed CAR T Cells Targeting High-risk and Refractory B Cell Lymphomas [Phase 1, Phase 2]